I caught myself being weird about food again. I was trying to get a colleague to eat some sriracha-flavoured edamame beans.

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

After cutting coverage because of cost, the state health plan could return GLP-1 weight loss drugs to the plan ...

Omada Health is joining forces with CVS Health's Caremark as part of the pharmacy benefit manager's weight management program ...

Anecdotal reports suggest drugs like Ozempic may curb not just appetite but also impulsive or addictive behaviour, hinting at ...

GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to ...

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

Losing weight is a common New Year’s resolution, and many people are now turning to advanced weight-loss medications like ...

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.